60-minute Program
Effective
dates for CE credit: 7/11/2024
– 5/1/2025
Description
The ADCES Advocacy Committee has created a presentation on advocacy for state CBs for the 118th Congress (2023-2024). The presentation will cover ADCES’ advocacy priorities, a policy 101 primer, the importance of advocacy for the DCES, key bills and regulations including recent policy wins, and opportunities to get involved. The presentation will be interactive with poll questions throughout, and time built in for attendees to complete action items on their phone/computer.
Learning Outcome
Learners will have an increased knowledge of current policy priorities and legislation impacting how diabetes care is delivered and will be able identify strategies to express their support for these priorities to their Members of Congress and other key decision-makers.
Activity Type
This recording of a live presentation
is a knowledge-based
learning activity.
Learning
Format
Enduring
Material
Intended Audience
This activity is designed for
individual or groups of diabetes care and education specialists, including nurses,
dietitians, pharmacists, pharmacy technicians, physicians, PAs, social workers,
and other health care providers interested in staying up to date on current
practices of care for people with diabetes and other related conditions.
Faculty Disclosures
In accordance with Joint Accreditation
criteria and the ACCME’s Standards for Integrity and Independence in Accredited
Continuing Education, the Association of Diabetes Care & Education
Specialists (ADCES) must ensure that anyone in a position to control the
content of the educational activity (planners and
speakers/authors/discussants/moderators) has disclosed all relevant financial
relationships with any ineligible companies for the past 24
months.
Joint
Accreditation/ACCME also requires that ADCES mitigate any reported conflict and
eliminate the potential for bias during the educational activity. The
disclosure information is intended to identify any ineligible relationships and
allow learners to form their own judgments. However, if you perceive a bias
during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof) among
educational activity planners and faculty are as follows:
Speakers
Hannah Martin, MPH, RDN- has no relevant financial disclosures to report
Planners
Hannah Martin, MPH, RDN - has no relevant financial disclosures to report.
Sara Mandy Reece, PharmD, BC-ADM, BCACP, FADCES - Consultant & Speaker: NovoNordisk; Consultant & Speaker: Dexcom; Consultant: Sanofi
Ann Constance, RD, CDCES, FADCES, MA - has no relevant financial disclosures to report
Andrea McCarty MS, RDN, LDN - has no relevant financial disclosures to report.
Gayle Jennings MS, RDN, BC-ADM, LDN, CDCES - has no relevant financial disclosures to report.
Iliana Guerra Martinez MHA, RD, LD, CDCES - Employment: Novo Nordisk
Janet Benefield MS, LD, RD, CDCES - has no relevant financial disclosures to report
Kirsten Robertson MS, RDN, LDN- - has no relevant financial disclosures to report
Leigh Bak APRN, CNS, MSN, CDCES - has no relevant financial disclosures to report
Lisa Graham RN, BSN, CDCES - has no relevant financial disclosures to report
Rosanne Ainscough RDN, CDCES - Pump Trainer: Omnipod
Teresa Martin RD, LD, CDCES - Employment: NovoNordisk
Wendy Mobley-Buckstein PharmD, CDCES - has no relevant financial disclosures to report
All relevant financial relationships
have been mitigated.
The
approval of this educational offering by the ADCES does not imply endorsement
of specific therapies, treatments, or products discussed in the
presentations.
Financial
Support
None
Access
Period
You
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity's CE credits expire (whichever comes
first).
Originally presented
on: 7/11/2024
Expiration
date: 5/1/202